| HOME >> MEDICINE >> TECHNOLOGY |
$
504,591
$
481,2644.82.32.5 Diabetes Care207,759187,98610.58.12.4 Pharmaceutical Systems268,982252,3836.67.3(0.7)TOTAL
$
981,332
$
921,6336.54.91.6BD DIAGNOSTICS Preanalytical Systems
$
306,239
$
287,6706.54.42.1 Diagnostic Systems299,108268,00211.69.02.6TOTAL
$
605,347
$
555,6728.96.52.4BD BIOSCIENCES Cell Analysis
$
255,516
$
242,4755.41.73.7 Discovery Labware79,82879,6290.2(3.3)3.5TOTAL
$
335,344
$
322,1044.10.43.7TOTAL REVENUES
$
1,922,023
$
1,799,4096.84.62.2BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY BUSINESS SEGMENTS AND UNITSSix Months Ended March 31,(Unaudited; Amounts in thousands)United States20112010 % Change BD MEDICAL Medical Surgical Systems
$
488,825
$
511,166(4.4) Diabetes Care195,524189,0793.4 Pharmaceutical Systems119,665114,0994.9TOTAL
$
804,014
$
814,344(1.3)BD DIAGNOSTICS Preanalytical Systems
$
319,036
$
306,1674.2 Diagnostic Systems300,431296,8781.2TOTAL
$
619,467
$
603,0452.7BD BIOSCIENCES Cell Analysis
$
163,262
$
155,7874.8 Discovery Labware71,04072,000(1.3)TOTAL
$
234,302
$
227,7872.9TOTAL UNITED STATES
$
1,657,783
$
1,645,1760.8BECTON DICKINSON AND COMPANYSUPPLEMENTAL REVENUE INFORMATIONREVENUES BY BUSINESS SEGMENTS AND UNITSSix Months Ended March 31, (continued)(Unaudited; Amounts in thousands)International % Change 20112010 Reported FXNFX ImpactBD M
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2010 PR Newswire. All rights reserved |